Ligand validation:1XIO

PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine

PEE is a Ligand Of Interest in 1XIO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1XIO_PEE_A_308	16%	51%	0.157	0.839	1.04	0.87	1	-	0	0	35%	0.3529
1XIO_PEE_A_302	14%	48%	0.17	0.843	0.94	1.08	1	2	0	0	29%	0.2941
1XIO_PEE_A_305	10%	41%	0.184	0.824	0.98	1.36	1	2	0	0	27%	0.2745
1XIO_PEE_A_309	7%	52%	0.192	0.756	1.01	0.87	1	-	1	0	35%	0.3529
1XIO_PEE_A_304	6%	48%	0.241	0.8	0.95	1.09	1	1	0	0	29%	0.2941
1XIO_PEE_A_306	5%	51%	0.202	0.726	1.02	0.88	1	-	0	0	35%	0.3529
1XIO_PEE_A_303	5%	47%	0.241	0.764	0.99	1.07	1	1	0	0	29%	0.2941
1XIO_PEE_A_312	4%	52%	0.236	0.721	1	0.85	1	-	1	0	35%	0.3529
1XIO_PEE_A_311	3%	48%	0.246	0.718	1.15	0.86	1	-	0	0	27%	0.2745
1XIO_PEE_A_307	3%	52%	0.283	0.712	1.02	0.86	1	-	0	0	35%	0.3529
1XIO_PEE_A_310	2%	49%	0.256	0.672	1.13	0.87	1	-	0	0	27%	0.2745
1XIO_PEE_A_313	2%	41%	0.266	0.695	0.87	1.46	1	2	0	0	20%	19.61
1XIO_PEE_A_315	2%	41%	0.293	0.723	0.88	1.46	1	2	0	0	20%	19.61
4TL3_PEE_B_304	19%	52%	0.156	0.876	1.01	0.84	1	-	3	0	29%	0.2941
1PPJ_PEE_C_2007	54%	48%	0.18	0.954	1.25	0.76	5	2	0	0	96%	0.9608
3B74_PEE_A_311	53%	41%	0.138	0.924	1.2	1.13	2	3	4	0	86%	0.8627
3Q8G_PEE_A_311	49%	48%	0.139	0.912	1.1	0.91	2	1	1	0	86%	0.8627
6A9J_PEE_A_401	46%	48%	0.151	0.886	1.05	0.96	3	1	4	0	100%	1
1PP9_PEE_Q_3006	45%	47%	0.18	0.914	1.31	0.78	6	2	9	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.